interventional
N/A
1 country
7
The primary objective is to evaluate the safety of PolyCore through continuous monitoring of adverse events, vital signs, and laboratory parameters.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 3, 2025
Actual (reported)Adverse Events (during the whole study)
Physical Examination (at every visit)
Vital Signs and body weight (at every visit)
Blood chemistry and hematology (at every visit)
24h diuresis analysis (at every visit)
24h dialysate analysis (at every visit)
Weekly Kt/V urea (evaluated at every visit)
Residual kidney function (at every visit)
Post-baseline profile of weekly Kt/V urea (at every visit)
Peritoneal ultrafiltration (at every visit and daily by patient diary)
Peritoneal and total sodium removal (at every visit)
Glycemic and lipidic parameters (at every visit)
Peritoneal clearances: creatinine, phosphate, B2-microglobulin, (at every visit)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
AOU Bologna Policlinico di Sant’Orsola
Bologna, 40138, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
Universita' Degli Studi G. D'Annunzio Di Chieti
Chieti, 66100, Italy
Dr. Arduino Arduini
First Submitted
March 3, 2025
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
Contact the study team to confirm eligibility.
Azienda ospedaliero universitaria -Universita degli Studi della Campania Luigi Vanvitelli
Napoli, Italy
Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli
Naples, 80138, Italy
Azienda Ospedaliera Universitaria Federico II Di Napoli
Naples, 80131, Italy
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Brescia, 25123, Italy